Candriam S.C.A. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$6,790,849
-28.9%
135,222
-10.6%
0.05%
-30.4%
Q2 2023$9,557,231
-49.2%
151,222
-66.7%
0.07%
-46.9%
Q1 2023$18,800,738
+66.1%
454,012
+75.8%
0.13%
+71.1%
Q4 2022$11,316,075
-33.5%
258,3110.0%0.08%
-36.7%
Q3 2022$17,021,000
+31.0%
258,311
+0.4%
0.12%
+12.1%
Q2 2022$12,990,000
+7.3%
257,172
+35.8%
0.11%
+30.5%
Q1 2022$12,101,000
-67.9%
189,441
-46.2%
0.08%
-66.0%
Q4 2021$37,728,000
+17.3%
352,243
+12.6%
0.24%
+10.0%
Q3 2021$32,173,000
+16.9%
312,9500.0%0.22%
+16.5%
Q2 2021$27,527,000
-27.4%
312,950
-11.1%
0.19%
-40.5%
Q1 2021$37,907,000
-3.9%
351,881
-0.0%
0.32%
+1.3%
Q4 2020$39,465,000
-20.3%
351,882
-34.1%
0.31%
-32.9%
Q3 2020$49,501,000
-27.8%
534,015
-39.2%
0.46%
-35.7%
Q2 2020$68,537,000
+686.9%
878,644
+689.9%
0.72%
+645.4%
Q1 2020$8,710,000
-2.2%
111,231
+0.0%
0.10%
+2.1%
Q4 2019$8,908,000
+153.6%
111,191
+147.1%
0.10%
+102.1%
Q3 2018$3,513,000
+25.8%
45,000
+2.3%
0.05%
+6.8%
Q2 2018$2,793,000
-30.8%
44,0000.0%0.04%
-36.2%
Q1 2018$4,035,000
+21.6%
44,0000.0%0.07%
+21.1%
Q4 2017$3,318,00044,0000.06%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders